Mason Street Advisors’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-7,210
Closed -$310K – 851
2020
Q4
$310K Sell
7,210
-41
-0.6% -$1.5K 0.01% 1313
2020
Q3
$226K Buy
7,251
+42
+0.6% +$1.3K ﹤0.01% 1311
2020
Q2
$231K Buy
7,209
+572
+9% +$19K ﹤0.01% 1299
2020
Q1
$186K Hold
6,637
– – ﹤0.01% 1298
2019
Q4
$306K Buy
6,637
+175
+3% +$8.23K 0.01% 1274
2019
Q3
$343K Buy
6,462
+97
+2% +$5K 0.01% 1216
2019
Q2
$337K Buy
6,365
+243
+4% +$12.9K 0.01% 1221
2019
Q1
$345K Buy
6,122
+246
+4% +$13.8K 0.01% 1254
2018
Q4
$308K Buy
5,876
+273
+5% +$15.5K 0.01% 1197
2018
Q3
$324K Buy
5,603
+156
+3% +$8.74K 0.01% 1239
2018
Q2
$309K Buy
5,447
+406
+8% +$23.1K 0.01% 1244
2018
Q1
$296K Buy
5,041
+315
+7% +$17.6K 0.01% 1219
2017
Q4
$259K Buy
4,726
+124
+3% +$6.43K 0.01% 1255
2017
Q3
$217K Buy
4,602
+152
+3% +$7.16K 0.01% 1297
2017
Q2
$207K Buy
4,450
+282
+7% +$11.7K 0.01% 1281
2017
Q1
$159K Buy
+4,168
New +$154K ﹤0.01% 1340

Other funds holding OFIX

Mason Street Advisors's OFIX Position: Q1 2021 in Review

Mason Street Advisors sold out of Orthofix Medical (OFIX) in Q1 2021, closing a stake of 7,210 shares — an estimated $310K sold.

Mason Street Advisors first reported a position in OFIX in Q1 2017 and held it in 16 quarters. The position peaked at $345K in Q1 2019. 140 funds tracked by Wall St. Rank hold OFIX as of Q1 2021.

  • Mason Street Advisors reported no remaining Orthofix Medical position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 7,210 Orthofix Medical shares in Q1 2021, an estimated $310K.
  • Mason Street Advisors first reported a position in Orthofix Medical in Q1 2017 and held it in 16 quarters.
  • Mason Street Advisors's Orthofix Medical position peaked at $345K in Q1 2019.
  • 140 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.